These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36634413)

  • 1. A novel phenotype of AChR-deficiency syndrome with predominant facial and distal weakness resulting from the inclusion of an evolutionary alternatively-spliced exon in CHRNA1.
    Rodríguez Cruz PM; Ravenscroft G; Natera D; Carr A; Manzur A; Liu WW; Vella NR; Jericó I; Gonzalez-Quereda L; Gallano P; Montalto SA; Davis MR; Lamont PJ; Laing NG; Bourque P; Nascimento A; Muntoni F; Polavarapu K; Lochmüller H; Palace J; Beeson D
    Neuromuscul Disord; 2023 Feb; 33(2):161-168. PubMed ID: 36634413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
    Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A
    Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome.
    Masuda A; Shen XM; Ito M; Matsuura T; Engel AG; Ohno K
    Hum Mol Genet; 2008 Dec; 17(24):4022-35. PubMed ID: 18806275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow-Channel Congenital Myasthenic Syndrome due to a Novel Mutation in the Acetylcholine Receptor Alpha Subunit in a South Asian: A Case Report.
    Gooneratne IK; Nandasiri S; Maxwell S; Webster R; Cossins J; Beeson D; Gunaratne K; Herath L; Senanayake S; Chang T
    J Neuromuscul Dis; 2021; 8(1):163-167. PubMed ID: 33216040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital Myasthenic Syndrome associated with acetylcholine receptor deficiency: case report and review of the literature.
    Batheja A; Bayer-Vile J; Silverstein E; Couser N
    Ophthalmic Genet; 2024 Oct; 45(5):481-487. PubMed ID: 38832364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-plate gamma- and epsilon-subunit mRNA levels in AChR deficiency syndrome due to epsilon-subunit null mutations.
    Croxen R; Young C; Slater C; Haslam S; Brydson M; Vincent A; Beeson D
    Brain; 2001 Jul; 124(Pt 7):1362-72. PubMed ID: 11408331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital myasthenic syndrome caused by low-expressor fast-channel AChR delta subunit mutation.
    Shen XM; Ohno K; Fukudome T; Tsujino A; Brengman JM; De Vivo DC; Packer RJ; Engel AG
    Neurology; 2002 Dec; 59(12):1881-8. PubMed ID: 12499478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CHRNE frameshift mutation causes congenital myasthenic syndrome in young Jack Russell Terriers.
    Rinz CJ; Lennon VA; James F; Thoreson JB; Tsai KL; Starr-Moss AN; Humphries HD; Guo LT; Palmer AC; Clark LA; Shelton GD
    Neuromuscul Disord; 2015 Dec; 25(12):921-7. PubMed ID: 26429099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome.
    Estephan EP; Sobreira CFDR; Dos Santos ACJ; Tomaselli PJ; Marques W; Ortega RPM; Costa MCM; da Silva AMS; Mendonça RH; Caldas VM; Zambon AA; Abath Neto O; Marchiori PE; Heise CO; Reed UC; Azuma Y; Töpf A; Lochmüller H; Zanoteli E
    J Neurol; 2018 Mar; 265(3):708-713. PubMed ID: 29383513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe congenital myasthenic syndrome due to homozygosity of the 1293insG epsilon-acetylcholine receptor subunit mutation.
    Sieb JP; Kraner S; Schrank B; Reitter B; Goebel TH; Tzartos SJ; Steinlein OK
    Ann Neurol; 2000 Sep; 48(3):379-83. PubMed ID: 10976646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.
    Gomez CM; Maselli RA; Vohra BP; Navedo M; Stiles JR; Charnet P; Schott K; Rojas L; Keesey J; Verity A; Wollmann RW; Lasalde-Dominicci J
    Ann Neurol; 2002 Jan; 51(1):102-12. PubMed ID: 11782989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital myasthenic syndrome (CMS) in three European kinships due to a novel splice mutation (IVS7 - 2 A/G) in the epsilon acetylcholine receptor (AChR) subunit gene.
    Barisic N; Schmidt C; Sidorova OP; Herczegfalvi A; Gekht BM; Song IH; Stucka R; Karcagi V; Abicht A; Lochmüller H
    Neuropediatrics; 2002 Oct; 33(5):249-54. PubMed ID: 12536367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splicing regulation and dysregulation of cholinergic genes expressed at the neuromuscular junction.
    Ohno K; Rahman MA; Nazim M; Nasrin F; Lin Y; Takeda JI; Masuda A
    J Neurochem; 2017 Aug; 142 Suppl 2():64-72. PubMed ID: 28072465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotide-mediated exon skipping of CHRNA1 pre-mRNA as potential therapy for Congenital Myasthenic Syndromes.
    Tei S; Ishii HT; Mitsuhashi H; Ishiura S
    Biochem Biophys Res Commun; 2015 Jun; 461(3):481-6. PubMed ID: 25888793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immature end-plates and utrophin deficiency in congenital myasthenic syndrome caused by epsilon-AChR subunit truncating mutations.
    Sieb JP; Kraner S; Rauch M; Steinlein OK
    Hum Genet; 2000 Aug; 107(2):160-4. PubMed ID: 11030414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Clinical Phenotypes in Congenital Myasthenic Syndrome Associated with the c.1327delG Frameshift Mutation in CHRNE Encoding the Acetylcholine Receptor Epsilon Subunit.
    Kastreva K; Chamova T; Blagoeva S; Bichev S; Mihaylova V; Meyer S; Thompson R; Cherninkova S; Guergueltcheva V; Lochmuller H; Tournev I
    J Neuromuscul Dis; 2024; 11(5):1011-1020. PubMed ID: 38995797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
    Andreux F; Hantaï D; Eymard B
    Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of slow-channel congenital myasthenic syndrome in a Thai family with fluoxetine.
    Dejthevaporn C; Wetchaphanphesat S; Pulkes T; Rattanasiri S; Engel AG; Witoonpanich R
    J Clin Neurosci; 2022 Feb; 96():85-89. PubMed ID: 34999496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin.
    Abicht A; Stucka R; Karcagi V; Herczegfalvi A; Horváth R; Mortier W; Schara U; Ramaekers V; Jost W; Brunner J; Janssen G; Seidel U; Schlotter B; Müller-Felber W; Pongratz D; Rüdel R; Lochmüller H
    Neurology; 1999 Oct; 53(7):1564-9. PubMed ID: 10534268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HnRNP L and hnRNP LL antagonistically modulate PTB-mediated splicing suppression of CHRNA1 pre-mRNA.
    Rahman MA; Masuda A; Ohe K; Ito M; Hutchinson DO; Mayeda A; Engel AG; Ohno K
    Sci Rep; 2013 Oct; 3():2931. PubMed ID: 24121633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.